← All organizations

ImmunGene Inc.

For profit

Also known as: ImmunGene, Inc.

Highest phase reached

Phase 2

First clinical trial

Dec 1, 2015

Last known activity

Aug 1, 2016

Acquired by Spectrum PharmaceuticalsRepligen Corporation on May 9, 2019

Timeline

2000s

  1. Jun 1, 2007

    ImmunGene Inc.— Founded

2010s

  1. Jun 27, 2017

    Repligen Corporation— Now

  2. May 9, 2019

    Spectrum Pharmaceuticals— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Recent trials (5)

Details

Founded
Thousand Oaks, CA, US Jun 1, 2007
Last known activity
Aug 1, 2016